{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:55:30Z","timestamp":1791190530637,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Nature Science Foundation of China","award":["No. 82474232"],"award-info":[{"award-number":["No. 82474232"]}]},{"name":"Basic Research Scheme of Shenzhen Science and Technology Innovation Commission","award":["(JCYJ20240813152305008"],"award-info":[{"award-number":["(JCYJ20240813152305008"]}],"id":[{"id":"https:\/\/ror.org\/017n8df75","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Basic Research Scheme of Shenzhen Science and Technology Innovation Commission","award":["JCYJ20230807094815031)"],"award-info":[{"award-number":["JCYJ20230807094815031)"]}],"id":[{"id":"https:\/\/ror.org\/017n8df75","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Scientific Research Project of Shenzhen Association of Chinese Medicine","award":["NO.2024077F"],"award-info":[{"award-number":["NO.2024077F"]}]},{"name":"2024 Guangzhou University of Chinese Medicine \u201cJie-bang Gua-shuai\u201d Graduate Innovation Capacity Enhancement Program","award":["A3-0317-24-429-015"],"award-info":[{"award-number":["A3-0317-24-429-015"]}],"id":[{"id":"https:\/\/ror.org\/03qb7bg95","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02343-3","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:25:22Z","timestamp":1780392322000},"page":"7457-7472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of cellular senescence in immune-metabolic features and prognosis of ovarian cancer: an integrated analysis based on single-cell sequencing and multi-omics data"],"prefix":"10.1007","volume":"48","author":[{"given":"Yuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"5","key":"2343_CR1","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/igc.0000000000001257","volume":"28","author":"Z Wang","year":"2018","unstructured":"Wang Z, Liu H, Xu C. Cellular senescence in the treatment of ovarian cancer. Int J Gynecol Cancer. 2018;28(5):895\u2013902. https:\/\/doi.org\/10.1097\/igc.0000000000001257.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"2343_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2343_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cell.2018.08.065","volume":"175","author":"F Coscia","year":"2018","unstructured":"Coscia F, Lengyel E, Duraiswamy J, Ashcroft B, Bassani-Sternberg M, Wierer M, et al. Multi-level proteomics identifies ct45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer. Cell. 2018;175(1):159-170.e116. https:\/\/doi.org\/10.1016\/j.cell.2018.08.065.","journal-title":"Cell"},{"issue":"33","key":"2343_CR4","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1200\/jco.21.00334","volume":"39","author":"J Hamanishi","year":"2021","unstructured":"Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, et al. Nivolumab versus gemcitabine or pegylated liposomal doxorubicin for patients with platinum-resistant ovarian cancer: open-label, randomized trial in Japan (ninja). J Clin Oncol. 2021;39(33):3671\u201381. https:\/\/doi.org\/10.1200\/jco.21.00334.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2343_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc2772","volume":"10","author":"M Collado","year":"2010","unstructured":"Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer. 2010;10(1):51\u20137. https:\/\/doi.org\/10.1038\/nrc2772.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2343_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14421-x","volume":"11","author":"T Montero-Melendez","year":"2020","unstructured":"Montero-Melendez T, Nagano A, Chelala C, Filer A, Buckley CD, Perretti M. Therapeutic senescence via GPCR activation in synovial fibroblasts facilitates resolution of arthritis. Nat Commun. 2020;11(1):745. https:\/\/doi.org\/10.1038\/s41467-020-14421-x.","journal-title":"Nat Commun"},{"issue":"15","key":"2343_CR7","doi-asserted-by":"publisher","first-page":"6928","DOI":"10.7150\/thno.43811","volume":"10","author":"H Sun","year":"2020","unstructured":"Sun H, Wang H, Wang X, Aoki Y, Wang X, Yang Y, et al. Aurora-a\/sox8\/foxk1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells. Theranostics. 2020;10(15):6928\u201345. https:\/\/doi.org\/10.7150\/thno.43811.","journal-title":"Theranostics"},{"issue":"5","key":"2343_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392\u2013401. https:\/\/doi.org\/10.1038\/nrc1877.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2343_CR9","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2024.12438","volume":"27","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Lou Y, Fang H, Sun S, Jin R, Ji Y, et al. Cancer\u2011associated fibroblasts under therapy\u2011induced senescence in the tumor microenvironment (review). Exp Ther Med. 2024;27(4):150. https:\/\/doi.org\/10.3892\/etm.2024.12438.","journal-title":"Exp Ther Med"},{"key":"2343_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apcsb.2022.11.007","volume":"135","author":"SN Zarneshan","year":"2023","unstructured":"Zarneshan SN, Fakhri S, Bachtel G, Bishayee A. Exploiting pivotal mechanisms behind the senescence-like cell cycle arrest in cancer. Adv Protein Chem Struct Biol. 2023;135:1\u201319. https:\/\/doi.org\/10.1016\/bs.apcsb.2022.11.007.","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"5","key":"2343_CR11","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/febs.16381","volume":"290","author":"M Takasugi","year":"2023","unstructured":"Takasugi M, Yoshida Y, Hara E, Ohtani N. The role of cellular senescence and SASP in tumour microenvironment. FEBS J. 2023;290(5):1348\u201361. https:\/\/doi.org\/10.1111\/febs.16381.","journal-title":"FEBS J"},{"issue":"12","key":"2343_CR12","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1002\/1878-0261.13042","volume":"15","author":"CR Chambers","year":"2021","unstructured":"Chambers CR, Ritchie S, Pereira BA, Timpson P. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer. Mol Oncol. 2021;15(12):3242\u201355. https:\/\/doi.org\/10.1002\/1878-0261.13042.","journal-title":"Mol Oncol"},{"issue":"1","key":"2343_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02096-7","volume":"23","author":"Z Dong","year":"2024","unstructured":"Dong Z, Luo Y, Yuan Z, Tian Y, Jin T, Xu F. Cellular senescence and SASP in tumor progression and therapeutic opportunities. Mol Cancer. 2024;23(1):181. https:\/\/doi.org\/10.1186\/s12943-024-02096-7.","journal-title":"Mol Cancer"},{"issue":"9","key":"2343_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.695","volume":"5","author":"L Ma","year":"2024","unstructured":"Ma L, Yu J, Fu Y, He X, Ge S, Jia R, et al. The dual role of cellular senescence in human tumor progression and therapy. MedComm. 2024;5(9):e695. https:\/\/doi.org\/10.1002\/mco2.695.","journal-title":"MedComm"},{"issue":"3","key":"2343_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/jb\/mvae079","volume":"177","author":"S Yamauchi","year":"2025","unstructured":"Yamauchi S, Takahashi A. Cellular senescence: mechanisms and relevance to cancer and aging. J Biochem. 2025;177(3):163\u20139. https:\/\/doi.org\/10.1093\/jb\/mvae079.","journal-title":"J Biochem"},{"issue":"1","key":"2343_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-01990-9","volume":"21","author":"RA Avelar","year":"2020","unstructured":"Avelar RA, Ortega JG, Tacutu R, Tyler EJ, Bennett D, Binetti P, et al. A multidimensional systems biology analysis of cellular senescence in aging and disease. Genome Biol. 2020;21(1):91. https:\/\/doi.org\/10.1186\/s13059-020-01990-9.","journal-title":"Genome Biol"},{"issue":"7","key":"2343_CR17","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/1354750x.2019.1652685","volume":"24","author":"L Xia","year":"2019","unstructured":"Xia L, Zhang W, Gao L. Clinical and prognostic effects of cdkn2a, cdkn2b and cdh13 promoter methylation in ovarian cancer: a study using meta-analysis and TCGA data. Biomarkers. 2019;24(7):700\u201311. https:\/\/doi.org\/10.1080\/1354750x.2019.1652685.","journal-title":"Biomarkers"},{"issue":"1","key":"2343_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-27445-2","volume":"13","author":"L Calapre","year":"2023","unstructured":"Calapre L, Giardina T, Beasley AB, Reid AL, Stewart C, Amanuel B, et al. Identification of tp53 mutations in circulating tumour DNA in high grade serous ovarian carcinoma using next generation sequencing technologies. Sci Rep. 2023;13(1):278. https:\/\/doi.org\/10.1038\/s41598-023-27445-2.","journal-title":"Sci Rep"},{"issue":"5","key":"2343_CR19","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.3390\/ijms26052232","volume":"26","author":"C Madeddu","year":"2025","unstructured":"Madeddu C, Lai E, Neri M, Sanna E, Gramignano G, Nemolato S, et al. Association between tp53 mutations and platinum resistance in a cohort of high-grade serous ovarian cancer patients: novel implications for personalized therapeutics. Int J Mol Sci. 2025;26(5):2232\u201349. https:\/\/doi.org\/10.3390\/ijms26052232.","journal-title":"Int J Mol Sci"},{"key":"2343_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ygyno.2024.03.023","volume":"186","author":"L Montemorano","year":"2024","unstructured":"Montemorano L, Shultz ZB, Farooque A, Hyun M, Chappell RJ, Hartenbach EM, et al. Tp53 mutations and the association with platinum resistance in high grade serous ovarian carcinoma. Gynecol Oncol. 2024;186:26\u201334. https:\/\/doi.org\/10.1016\/j.ygyno.2024.03.023.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"2343_CR21","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s42255-021-00483-8","volume":"3","author":"CD Wiley","year":"2021","unstructured":"Wiley CD, Campisi J. The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat Metab. 2021;3(10):1290\u2013301. https:\/\/doi.org\/10.1038\/s42255-021-00483-8.","journal-title":"Nat Metab"},{"issue":"1","key":"2343_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","volume":"20","author":"A Kalbasi","year":"2020","unstructured":"Kalbasi A, Ribas A. Tumour-intrinsic resistance to immune checkpoint blockade. Nat Rev Immunol. 2020;20(1):25\u201339. https:\/\/doi.org\/10.1038\/s41577-019-0218-4.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2343_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N, et al. Define cancer-associated fibroblasts (cafs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer. 2023;22(1):159. https:\/\/doi.org\/10.1186\/s12943-023-01860-5.","journal-title":"Mol Cancer"},{"key":"2343_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1582532","volume":"16","author":"X Lan","year":"2025","unstructured":"Lan X, Li W, Zhao K, Wang J, Li S, Zhao H. Revisiting the role of cancer-associated fibroblasts in tumor microenvironment. Front Immunol. 2025;16:1582532. https:\/\/doi.org\/10.3389\/fimmu.2025.1582532.","journal-title":"Front Immunol"},{"key":"2343_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.684505","volume":"9","author":"Z Ji","year":"2021","unstructured":"Ji Z, Tian W, Gao W, Zang R, Wang H, Yang G. Cancer-associated fibroblast-derived interleukin-8 promotes ovarian cancer cell stemness and malignancy through the notch3-mediated signaling. Front Cell Dev Biol. 2021;9:684505. https:\/\/doi.org\/10.3389\/fcell.2021.684505.","journal-title":"Front Cell Dev Biol"},{"key":"2343_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1635771","volume":"16","author":"G Ruan","year":"2025","unstructured":"Ruan G, Wang X, Ou H, Guo D. Cancer-associated fibroblasts: dual roles from senescence sentinels to death regulators and new dimensions in therapy. Front Immunol. 2025;16:1635771. https:\/\/doi.org\/10.3389\/fimmu.2025.1635771.","journal-title":"Front Immunol"},{"issue":"18","key":"2343_CR27","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1002\/1878-0261.13268","volume":"16","author":"M Takasugi","year":"2022","unstructured":"Takasugi M, Yoshida Y, Ohtani N. Cellular senescence and the tumour microenvironment. Mol Oncol. 2022;16(18):3333\u201351. https:\/\/doi.org\/10.1002\/1878-0261.13268.","journal-title":"Mol Oncol"},{"issue":"1","key":"2343_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38093-5","volume":"14","author":"EH Puttock","year":"2023","unstructured":"Puttock EH, Tyler EJ, Manni M, Maniati E, Butterworth C, Burger Ramos M, et al. Extracellular matrix educates an immunoregulatory tumor macrophage phenotype found in ovarian cancer metastasis. Nat Commun. 2023;14(1):2514. https:\/\/doi.org\/10.1038\/s41467-023-38093-5.","journal-title":"Nat Commun"},{"key":"2343_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.971479","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Zhang X, Wang Z, Zheng W, Cao H, Shen W. Targeting oxidative phosphorylation as an approach for the treatment of ovarian cancer. Front Oncol. 2022;12:971479. https:\/\/doi.org\/10.3389\/fonc.2022.971479.","journal-title":"Front Oncol"},{"issue":"1","key":"2343_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03447-y","volume":"20","author":"S Sriramkumar","year":"2022","unstructured":"Sriramkumar S, Sood R, Huntington TD, Ghobashi AH, Vuong TT, Metcalfe TX, et al. Platinum-induced mitochondrial oxphos contributes to cancer stem cell enrichment in ovarian cancer. J Transl Med. 2022;20(1):246. https:\/\/doi.org\/10.1186\/s12967-022-03447-y.","journal-title":"J Transl Med"},{"issue":"1","key":"2343_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-024-01356-w","volume":"17","author":"M Du","year":"2024","unstructured":"Du M, Cai Q, Sun J, Zhang M, Zhang S, Liu X, et al. Aneuploid serves as a prognostic marker and favors immunosuppressive microenvironment in ovarian cancer. J Ovarian Res. 2024;17(1):30. https:\/\/doi.org\/10.1186\/s13048-024-01356-w.","journal-title":"J Ovarian Res"},{"issue":"1","key":"2343_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/biomedicines11010190","volume":"11","author":"S Muto","year":"2023","unstructured":"Muto S, Enta A, Maruya Y, Inomata S, Yamaguchi H, Mine H, et al. Wnt\/\u03b2-catenin signaling and resistance to immune checkpoint inhibitors: from non-small-cell lung cancer to other cancers. Biomedicines. 2023;11(1):190\u2013204. https:\/\/doi.org\/10.3390\/biomedicines11010190.","journal-title":"Biomedicines"},{"key":"2343_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1476904","volume":"15","author":"B Zhang","year":"2024","unstructured":"Zhang B, Liu J, Mo Y, Zhang K, Huang B, Shang D. CD8(+) t cell exhaustion and its regulatory mechanisms in the tumor microenvironment: Key to the success of immunotherapy. Front Immunol. 2024;15:1476904. https:\/\/doi.org\/10.3389\/fimmu.2024.1476904.","journal-title":"Front Immunol"},{"issue":"1","key":"2343_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1249561","volume":"6","author":"RY Huang","year":"2017","unstructured":"Huang RY, Francois A, McGray AR, Miliotto A, Odunsi K. Compensatory upregulation of pd-1, lag-3, and ctla-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer. Oncoimmunology. 2017;6(1):e1249561. https:\/\/doi.org\/10.1080\/2162402x.2016.1249561.","journal-title":"Oncoimmunology"},{"key":"2343_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115569","volume":"167","author":"P Zhang","year":"2023","unstructured":"Zhang P, Wang Y, Miao Q, Chen Y. The therapeutic potential of pd-1\/pd-l1 pathway on immune-related diseases: Based on the innate and adaptive immune components. Biomed Pharmacother. 2023;167:115569. https:\/\/doi.org\/10.1016\/j.biopha.2023.115569.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2343_CR36","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/cas.15756","volume":"114","author":"T Watanabe","year":"2023","unstructured":"Watanabe T, Ishino T, Ueda Y, Nagasaki J, Sadahira T, Dansako H, et al. Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunity. Cancer Sci. 2023;114(5):1859\u201370. https:\/\/doi.org\/10.1111\/cas.15756.","journal-title":"Cancer Sci"},{"issue":"10","key":"2343_CR37","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3390\/jcm8101658","volume":"8","author":"M Teeuwssen","year":"2019","unstructured":"Teeuwssen M, Fodde R. Wnt signaling in ovarian cancer stemness, emt, and therapy resistance. J Clin Med. 2019;8(10):1658\u201380. https:\/\/doi.org\/10.3390\/jcm8101658.","journal-title":"J Clin Med"},{"key":"2343_CR38","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2021.0004","author":"S Yu","year":"2022","unstructured":"Yu S, Pen X, Zheng H, Gao Q, Wang H. Downregulated wnt2b expression suppresses proliferation, invasion, and angiogenesis of ovarian cancer cells through inhibiting the wnt\/\u03b2-catenin signaling pathway. Cancer Biother Radiopharm. 2022. https:\/\/doi.org\/10.1089\/cbr.2021.0004.","journal-title":"Cancer Biother Radiopharm"},{"key":"2343_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.916251","volume":"12","author":"N Zhao","year":"2022","unstructured":"Zhao N, Xing Y, Hu Y, Chang H. Exploration of the immunotyping landscape and immune infiltration-related prognostic markers in ovarian cancer patients. Front Oncol. 2022;12:916251. https:\/\/doi.org\/10.3389\/fonc.2022.916251.","journal-title":"Front Oncol"},{"issue":"1","key":"2343_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13048-024-01482-5","volume":"17","author":"S Sarkar","year":"2024","unstructured":"Sarkar S, Saha SA, Swarnakar A, Chakrabarty A, Dey A, Sarkar P, et al. The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer. J Ovarian Res. 2024;17(1):159. https:\/\/doi.org\/10.1186\/s13048-024-01482-5.","journal-title":"J Ovarian Res"},{"key":"2343_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150348","volume":"729","author":"C Samant","year":"2024","unstructured":"Samant C, Kale R, Pai KSR, Nandakumar K, Bhonde M. Role of wnt\/\u03b2-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors. Biochem Biophys Res Commun. 2024;729:150348. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150348.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2343_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-025-01488-8","volume":"17","author":"K Nesic","year":"2025","unstructured":"Nesic K, Parker P, Swisher EM, Krais JJ. DNA repair and the contribution to chemotherapy resistance. Genome Med. 2025;17(1):62. https:\/\/doi.org\/10.1186\/s13073-025-01488-8.","journal-title":"Genome Med"},{"issue":"1","key":"2343_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02693-w","volume":"22","author":"M Taheri","year":"2022","unstructured":"Taheri M, Hussen BM, Najafi S, Abak A, Ghafouri-Fard S, Samsami M, et al. Molecular mechanisms of inhibitor of growth (ing) family members in health and malignancy. Cancer Cell Int. 2022;22(1):272. https:\/\/doi.org\/10.1186\/s12935-022-02693-w.","journal-title":"Cancer Cell Int"},{"key":"2343_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115102","volume":"248","author":"X Xin","year":"2023","unstructured":"Xin X, Wang Y, Zhang L, Zhang D, Sha L, Zhu Z, et al. Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases. Eur J Med Chem. 2023;248:115102. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115102.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"2343_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1946","volume":"7","author":"DV Maybee","year":"2023","unstructured":"Maybee DV, Cromwell CR, Hubbard BP, Ali MAM. Mmp-2 regulates src activation via repression of the chk\/matk tumor suppressor in osteosarcoma. Cancer Rep (Hoboken). 2023;7(2):e1946. https:\/\/doi.org\/10.1002\/cnr2.1946.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"3","key":"2343_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/kjm2.12786","volume":"40","author":"C Zhang","year":"2024","unstructured":"Zhang C, Wang W, Wu B. Molecular mechanism of wwp1-mediated ubiquitination modification affecting proliferation and invasion\/migration of liver cancer cells. Kaohsiung J Med Sci. 2024;40(3):255\u201368. https:\/\/doi.org\/10.1002\/kjm2.12786.","journal-title":"Kaohsiung J Med Sci"},{"key":"2343_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113860","volume":"156","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Paskeh MDA, Entezari M, Mirmazloomi SR, Hassanpoor A, Aboutalebi M, et al. Sox2 function in cancers: association with growth, invasion, stemness and therapy response. Biomed Pharmacother. 2022;156:113860. https:\/\/doi.org\/10.1016\/j.biopha.2022.113860.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2343_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.20517\/cdr.2022.146","volume":"6","author":"S Bouberhan","year":"2023","unstructured":"Bouberhan S, Bar-Peled L, Matoba Y, Mazina V, Philp L, Rueda BR. The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer. Cancer Drug Resist. 2023;6(2):345\u201357. https:\/\/doi.org\/10.20517\/cdr.2022.146.","journal-title":"Cancer Drug Resist"},{"key":"2343_CR49","doi-asserted-by":"publisher","DOI":"10.3892\/or.2022.8293","author":"L Yang","year":"2022","unstructured":"Yang L, Xie HJ, Li YY, Wang X, Liu XX, Mai J. Molecular mechanisms of platinum\u2011based chemotherapy resistance in ovarian cancer (review). Oncol Rep. 2022. https:\/\/doi.org\/10.3892\/or.2022.8293.","journal-title":"Oncol Rep"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02343-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:29:02Z","timestamp":1791188942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02343-3","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}